Hutch News

Hutch News

Stories tagged 'cancer recurrence'

A new blood test detects recurrence of rare skin cancer

$200 assay can accurately signal return of Merkel cell carcinoma — in some cases catching tumors earlier than expensive imaging

Dec. 12, 2016 | By Rachel Tompa / Fred Hutch News Service

Fred Hutch and UW researchers have developed an inexpensive blood test to catch recurrences of Merkel cell carcinoma -- in some cases the tests finds tumors earlier than traditional imaging.

View story >


Drinking after diagnosis

Alcohol use after breast cancer doesn’t increase your chances of dying of the disease, new study shows, but it does increase overall cancer risk

June 10, 2016 | By Diane Mapes / Fred Hutch News Service

Alcohol use can raise your breast cancer risk. But what does it mean when you've already been diagnosed with the disease? Fred Hutch's Dr. Christopher Li talks about his new study on the subject.

View story >


High-throughput sequencing outpaces flow cytometry for earliest detection of cancer relapse

Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method

May 21, 2012 | By Kristen Woodward

A study led by Fred Hutchinson Cancer Research Center Public Health Sciences Division computational biologist Dr. Harlan Robins has found that a next-generation, high-speed DNA-decoding technology called high-throughput sequencing can detect the earliest signs of potential relapse in nearly twice the number of leukemia patients as compared to flow cytometry, the current gold standard for detecting minimal residual disease.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.